Effects of NSAIDs on pre‑osteoblast viability and osteogenic differentiation

Hadjicharalambous,Chrystalleni; Alpantaki,Kalliopi; Chatzinikolaidou,Maria

doi:10.3892/etm.2021.10172

Effects of NSAIDs on pre‑osteoblast viability and osteogenic differentiation

Authors:
- Chrystalleni Hadjicharalambous
- Kalliopi Alpantaki
- Maria Chatzinikolaidou
View Affiliations

Affiliations: Department of Materials Science and Technology, University of Crete, Heraklion 70013, Greece, Department of Orthopedics and Trauma, Venizeleion General Hospital of Heraklion, Heraklion 71409, Greece
Published online on: May 10, 2021 https://doi.org/10.3892/etm.2021.10172
Article Number: 740

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Non‑steroidal anti‑inflammatory drugs (NSAIDs) are widely used in the treatment of a variety of musculoskeletal conditions, injuries and after surgery for postoperative pain management. Their use has been associated with impaired bone healing, possibly due to a multifactorial function, which may include inhibition of osteoblast recruitment and differentiation. However, up to date, there is no consensus regarding the impact of NSAIDs on bone‑healing. The aim of the current study was to investigate the effects of five NSAIDs on the cellular functions of mouse MC3T3‑E1 pre‑osteoblasts. Cells were treated with the non‑selective COX inhibitors lornoxicam and diclofenac, the COX‑2 selective inhibitors parecoxib, meloxicam and paracetamol, as well as steroidal prednisolone at different doses and exposure times. The PrestoBlue™ technique was used to measure cell viability, an enzymatic assay was employed for alkaline phosphatase (ALP) activity and alizarin red S mineral staining was used to determine osteogenic differentiation. All drugs had a negative impact on pre‑osteoblast cell growth, with the exception of paracetamol. Lornoxicam, diclofenac and meloxicam reduced ALP activity, while the other NSAIDs had no effect and prednisolone strongly increased ALP activity. In contrast, calcium deposits were either unaffected or increased by NSAID treatments but were significantly decreased by prednisolone. These results provide evidence that NSAIDs may adversely affect the viability of mouse pre‑osteoblast cells but their actions on the osteogenic differentiation are drug‑specific. The direct comparison of the effects of different NSAIDs and prednisolone on pre‑osteoblasts may serve to place some NSAIDs in a preferential position for analgesic and anti‑inflammatory therapy during bone repair.

View Figures

View References

1	Barry S: Non-steroidal anti-inflammatory drugs inhibit bone healing: A review. Vet Comp Orthop Traumatol. 23:385–392. 2010.PubMed/NCBI View Article : Google Scholar
2	Cottrell J and O'Connor JP: Effect of non-steroidal anti-inflammatory drugs on bone healing. Pharmaceuticals (Basel). 3:1668–1693. 2010.PubMed/NCBI View Article : Google Scholar
3	Pountos I, Georgouli T, Blokhuis TJ, Pape HC and Giannoudis PV: Pharmacological agents and impairment of fracture healing: What is the evidence? Injury. 39:384–394. 2008.PubMed/NCBI View Article : Google Scholar
4	Patschan D, Loddenkemper K and Buttgereit F: Molecular mechanisms of glucocorticoid-induced osteoporosis. Bone. 29:498–505. 2001.PubMed/NCBI View Article : Google Scholar
5	Canalis E: Mechanisms of glucocorticoid action in bone. Curr Osteoporos Rep. 3:98–102. 2005.PubMed/NCBI View Article : Google Scholar
6	O'Brien CA, Jia D, Plotkin LI, Bellido T, Powers CC, Stewart SA, Manolagas SC and Weinstein RS: Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology. 145:1835–1841. 2004.PubMed/NCBI View Article : Google Scholar
7	Paget S: Steroids cause osteoporosis. Ann Rheum Dis. 61:1–3. 2002.PubMed/NCBI View Article : Google Scholar
8	Harder AT and An YH: The mechanisms of the inhibitory effects of nonsteroidal anti-inflammatory drugs on bone healing: A concise review. J Clin Pharmacol. 43:807–815. 2003.PubMed/NCBI View Article : Google Scholar
9	Pountos I, Georgouli T, Calori GM and Giannoudis PV: Do nonsteroidal anti-inflammatory drugs affect bone healing? A critical analysis. ScientificWorldJournal. 2012(606404)2012.PubMed/NCBI View Article : Google Scholar
10	Chang JK, Li CJ, Wu SC, Yeh CH, Chen CH, Fu YC, Wang GJ and Ho ML: Effects of anti-inflammatory drugs on proliferation, cytotoxicity and osteogenesis in bone marrow mesenchymal stem cells. Biochem Pharmacol. 74:1371–1382. 2007.PubMed/NCBI View Article : Google Scholar
11	García-Martínez O, De Luna-Bertos E, Ramos-Torrecillas J, Manzano-Moreno FJ and Ruiz C: Repercussions of NSAIDS drugs on bone tissue: The osteoblast. Life Sci. 123:72–77. 2015.PubMed/NCBI View Article : Google Scholar
12	Díaz-Rodríguez L, García-Martínez O, De Luna-Bertos E, Ramos-Torrecillas J and Ruiz C: Effect of ibuprofen on proliferation, differentiation, antigenic expression, and phagocytic capacity of osteoblasts. J Bone Miner Metab. 30:554–560. 2012.PubMed/NCBI View Article : Google Scholar
13	De Luna-Bertos E, Ramos-Torrecillas J, García-Martínez O, Guildford A, Santin M and Ruiz C: Therapeutic doses of nonsteroidal anti-inflammatory drugs inhibit osteosarcoma MG-63 osteoblast-like cells maturation, viability, and biomineralization potential. ScientificWorldJournal. 2013(809891)2013.PubMed/NCBI View Article : Google Scholar
14	Costela-Ruiz VJ, Melguizo-Rodríguez L, Illescas-Montes R, Ramos-Torrecillas J, Manzano-Moreno FJ, Ruiz C and Bertos EL: Effects of therapeutic doses of celecoxib on several physiological parameters of cultured human osteoblasts. Int J Med Sci. 16:1466–1472. 2019.PubMed/NCBI View Article : Google Scholar
15	Wheatley BM, Nappo KE, Christensen DL, Holman AM, Brooks DI and Potter BK: Effect of NSAIDs on bone healing rates: A meta-analysis. J Am Acad Orthop Surg. 27:e330–e336. 2019.PubMed/NCBI View Article : Google Scholar
16	Lisowska B, Kosson D and Domaracka K: Positives and negatives of nonsteroidal anti-inflammatory drugs in bone healing: The effects of these drugs on bone repair. Drug Des Devel Ther. 12:1809–1814. 2018.PubMed/NCBI View Article : Google Scholar
17	Geusens P, Emans PJ, de Jong JJ and van den Bergh J: NSAIDs and fracture healing. Curr Opin Rheumatol. 25:524–531. 2013.PubMed/NCBI View Article : Google Scholar
18	Beck A, Salem K, Krischak G, Kinzl L, Bischoff M and Schmelz A: Nonsteroidal anti-inflammatory drugs (NSAIDs) in the perioperative phase in traumatology and orthopedics effects on bone healing. Oper Orthop Traumatol. 17:569–578. 2005.PubMed/NCBI View Article : Google Scholar : (In English, German).
19	Gerstenfeld LC, Thiede M, Seibert K, Mielke C, Phippard D, Svagr B, Cullinane D and Einhorn TA: Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. J Orthop Res. 21:670–675. 2003.PubMed/NCBI View Article : Google Scholar
20	Herbenick MA, Sprott D, Stills H and Lawless M: Effects of a cyclooxygenase 2 inhibitor on fracture healing in a rat model. Am J Orthop (Belle Mead NJ). 37:E133–E137. 2008.PubMed/NCBI
21	Manzano-Moreno FJ, Costela-Ruiz VJ, Melguizo-Rodriguez L, Illescas-Montes R, García-Martínez O, Ruiz C and Ramos-Torrecillas J: Inhibition of VEGF gene expression in osteoblast cells by different NSAIDs. Arch Oral Biol. 92:75–78. 2018.PubMed/NCBI View Article : Google Scholar
22	Hadjicharalambous C, Alexaki VI, Alpantaki K and Chatzinikolaidou M: Effects of NSAIDs on the osteogenic differentiation of human adipose tissue-derived stromal cells. J Pharm Pharmacol. 68:1403–1408. 2016.PubMed/NCBI View Article : Google Scholar
23	Jain NX, Barr-Gillespie AE, Clark BD, Kietrys DM, Wade CK, Litvin J, Popoff SN and Barbe MF: Bone loss from high repetitive high force loading is prevented by ibuprofen treatment. J Musculoskelet Neuronal Interact. 14:78–94. 2014.PubMed/NCBI
24	Darnis D, Veyrac G and Jolliet P: The special case of diclofenac. Enliven: Pharmacovigil Drug Saf. 1(3)2014.
25	Schwarting T, Pretzsch S, Debus F, Ruchholtz S and Lechler P: The effect of cyclooxygenase inhibition on tendon-bone healing in an in vitro coculture model. Med Inflammation. 2015(926369)2015.PubMed/NCBI View Article : Google Scholar
26	Kidd LJ, Cowling NR, Wu AC, Kelly WL and Forwood MR: Selective and non-selective cyclooxygenase inhibitors delay stress fracture healing in the rat ulna. J Orthop Res. 31:235–242. 2013.PubMed/NCBI View Article : Google Scholar
27	Vuolteenaho K, Moilanen T and Moilanen E: Non-steroidal anti-inflammatory drugs, cyclooxygenase-2 and the bone healing process. Basic Clin Pharmacol Toxicol. 102:10–14. 2008.PubMed/NCBI View Article : Google Scholar
28	Marquez-Lara A, Hutchinson ID, Nunez F Jr, Smith TL and Miller AN: Nonsteroidal anti-inflammatory drugs and bone-healing: A systematic review of research quality. JBJS Rev. 4(01874474-201603000-00005)2016.PubMed/NCBI View Article : Google Scholar
29	Graham GG, Davies MJ, Day RO, Mohamudally A and Scott KF: The modern pharmacology of paracetamol: Therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology. 21:201–232. 2013.PubMed/NCBI View Article : Google Scholar
30	Kodama H, Amagai Y, Sudo H and Yamamoto S: Establishment of a clonal osteogenic cell line from newborn mouse calvaria. Jpn J Oral Biol. 23:899–901. 1981.
31	Golub E and Boesze-Battaglia KJ: The role of alkaline phosphatase in mineralization. Curr Opin Orthopaedics. 18:444–448. 2007.
32	Hadjicharalambous C, Buyakov A, Buyakova S, Kulkov S and Chatzinikolaidou M: Porous alumina, zirconia and alumina/zirconia for bone repair: fabrication, mechanical and in vitro biological response. Biomed Mater. 10(025012)2015.PubMed/NCBI View Article : Google Scholar
33	Feng Y, Su L, Zhong X, Guohong W, Xiao H, Li Y and Xiu L: Exendin-4 promotes proliferation and differentiation of MC3T3-E1 osteoblasts by MAPKs activation. J Mol Endocrinol. 56:189–199. 2016.PubMed/NCBI View Article : Google Scholar
34	Hadjicharalambous C, Kozlova D, Sokolova V, Epple M and Chatzinikolaidou M: Calcium phosphate nanoparticles carrying BMP-7 plasmid DNA induce an osteogenic response in MC3T3-E1 pre-osteoblasts. J Biomed Mater Res A. 103:3834–3842. 2015.PubMed/NCBI View Article : Google Scholar
35	Evans CE and Butcher C: The influence on human osteoblasts in vitro of non-steroidal anti-inflammatory drugs which act on different cyclooxygenase enzymes. J Bone Joint Surg Br. 86:444–449. 2004.PubMed/NCBI View Article : Google Scholar
36	Arpornmaeklong P, Akarawatcharangura B and Pripatnanont P: Factors influencing effects of specific COX-2 inhibitor NSAIDs on growth and differentiation of mouse osteoblasts on titanium surfaces. Int J Oral Maxillofac Implants. 23:1071–1081. 2008.PubMed/NCBI
37	Gunaydin C and Bilge SS: Effects of nonsteroidal anti-inflammatory drugs at the molecular level. Eurasian J Med. 50:116–121. 2018.PubMed/NCBI View Article : Google Scholar
38	Kotake S, Yago T, Kawamoto M and Nanke Y: Effects of NSAIDs on differentiation and function of human and murine osteoclasts-crucial ‘Human osteoclastology’. Pharmaceuticals (Basel). 3:1394–1410. 2010.PubMed/NCBI View Article : Google Scholar
39	Pountos I, Giannoudis PV, Jones E, English A, Churchman S, Field S, Ponchel F, Bird H, Emery P and McGonagle D: NSAIDS inhibit in vitro MSC chondrogenesis but not osteogenesis: Implications for mechanism of bone formation inhibition in man. J Cell Mol Med. 15:525–534. 2011.PubMed/NCBI View Article : Google Scholar
40	Hinz B, Cheremina O and Brune K: Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man. FASEB J. 22:383–390. 2008.PubMed/NCBI View Article : Google Scholar
41	Díaz-Rodríguez L, García-Martínez O, Arroyo-Morales M, Rubio-Ruiz B and Ruiz C: Effect of acetaminophen (paracetamol) on human osteosarcoma cell line MG63. Acta Pharmacol Sin. 31:1495–1499. 2010.PubMed/NCBI View Article : Google Scholar
42	Melguizo-Rodriguez L, Costela-Ruiz VJ, Manzano-Moreno FJ, Illescas-Montes R, Ramos-Torrecillas J, García-Martínez O and Ruiz C: Repercussion of nonsteroidal anti-inflammatory drugs on the gene expression of human osteoblasts. PeerJ. 6(e5415)2018.PubMed/NCBI View Article : Google Scholar
43	Nakatsu Y, Nakagawa F, Higashi S, Ohsumi T, Shiiba S, Watanabe S and Takeuchi H: Effect of acetaminophen on osteoblastic differentiation and migration of MC3T3-E1 cells. Pharmacol Rep. 70:29–36. 2018.PubMed/NCBI View Article : Google Scholar
44	Sivagurunathan S, Muir MM, Brennan TC, Seale JP and Mason RS: Influence of glucocorticoids on human osteoclast generation and activity. J Bone Miner Res. 20:390–398. 2005.PubMed/NCBI View Article : Google Scholar
45	Mitra R: Adverse effects of corticosteroids on bone metabolism: A review. PM R. 3:466–471. 2011.PubMed/NCBI View Article : Google Scholar
46	Hong D, Chen HX, Ge RS and Li JC: The biological roles of extracellular and intracytoplasmic glucocorticoids in skeletal cells. J Steroid Biochem Mol Biol. 111:164–170. 2008.PubMed/NCBI View Article : Google Scholar
47	Nagano A, Arioka M, Takahashi-Yanaga F, Matsuzaki E and Sasaguri T: Celecoxib inhibits osteoblast maturation by suppressing the expression of Wnt target genes. J Pharmacol Sci. 133:18–24. 2017.PubMed/NCBI View Article : Google Scholar
48	Hachemi Y, Rapp AE, Picke AK, Weidinger G, Ignatius A and Tuckermann J: Molecular mechanisms of glucocorticoids on skeleton and bone regeneration after fracture. J Mol Endocrinol. 61:R75–R90. 2018.PubMed/NCBI View Article : Google Scholar
49	Asirvatham S, Dhokchawle BV and Tauro SJ: Quantitative structure activity relationships studies of non-steroidal anti-inflammatory drugs: A review. Arabian J Chem. 12:3948–3962. 2019.
50	Michaelidou AS and Hadjipavlou-Litina D: Nonsteroidal anti-inflammatory drugs (NSAIDs): A comparative QSAR study. Chem Rev. 105:3235–3271. 2005.PubMed/NCBI View Article : Google Scholar